AMGN vs LEA · P/E 24, rev $10.05B vs P/E 14, rev $12.03B
Amgen Inc (AMGN) versus Lear Corporation (LEA) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Lear Corporation (LEA) is a auto parts company listed on US.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported LEA revenue for 2026-07-04 was $12.03B. Net income was $365.1M. LEA currently screens at market cap $7.21B and trailing P/E 14.4.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. LEA currently screens at market cap $7.21B and trailing P/E 14.4.
Not investment advice. Open the AMGN and LEA stock pages for the full models.
Not investment advice.